期刊文献+

氯胺酮相关性膀胱炎评分分期的影响因素评估

Evaluation on Influencing Factors of Ketamine-Associated Cystitis Grading System
在线阅读 下载PDF
导出
摘要 目的通过回顾性分析氯胺酮相关性膀胱炎(KC)患者的临床资料,建立KC评分分期系统,评估疾病分期的影响因素。方法回顾性分析我院收治的57例KC患者的临床资料,获得临床分期。建立KC评分分期系统,多因素回归分析评估KC分期的影响因素。结果多元回归方程是Y=0.696+0.016X1+0.229X2+0.111X3+0.273X4,分析显示尿沉渣分析、泌尿系统CT/膀胱造影、尿流动力学指标是KC评分分期的影响因素。结论尿沉渣分析、泌尿系统CT/膀胱造影、尿流动力学指标等是KC评分分期的影响因素。 Objective Through a retrospective analysis of the clinical data of patietns with ketamine-associated cystitis(KC),the KC grading system was established,and the influencing factors of disease staging were evaluated.Methods The clinical data of 57 cases of KC patients admitted to our hospital were retrospectively analyzed,the clinical grading was obtained.The KC grading system was established,and multivariate regression analysis was used to evaluate the influencing factors of KC grading.Results The multiple regression equation was Y=0.696+0.016X1+0.229X2+0.111X3+0.273X4.The analysis showed that urinary sediment analysis,CT/cystography of urinary system and urodynamic indicators were the influencing factors of KC grading.Conclusions Urinary sediment analysis,CT/cystography of urinary system and urodynamic indicators are the influencing factors of KC grading.
作者 赖香茂 刘晓萍 潘楚灶 刘建家 杨曦 曾健文 LAI Xiangmao;LIU Xiaoping;PAN Chuzao;LIU Jianjia;YANG Xi;ZENG Jianwen(Department of Urology,the Sixth Affiliated Hospital of Guangzhou Medical University/Qingyuan People's Hospital,Qingyuan 511518,China;Department of Pharmacy,the Sixth Affiliated Hospital of Guangzhou Medical University/Qingyuan People's Hospital,Qingyuan 511518,China)
出处 《临床医学工程》 2020年第1期119-120,共2页 Clinical Medicine & Engineering
基金 清远市科技计划重点项目(项目编号:2012A011203004)
关键词 氯胺酮相关性膀胱炎 评分分期 影响因素 Ketamine-associated cystitis Grading Influencing factor
  • 相关文献

参考文献3

二级参考文献47

  • 1张帆,李静.氯胺酮滥用合并焦虑障碍一例[J].中国药物依赖性杂志,2005,14(1):23-23. 被引量:1
  • 2刘志民,李密,曹家琪,孙文林,孙桂宽,吕宪祥,赵成正,赵苳,蔡志基.赤峰市部分地区阿片滥用者流行学调查[J].中国药物依赖性通报,1992,1(2):83-87. 被引量:7
  • 3Mathias R. Ketamine, PCP, and alcohol trigger widespread cell death in the brain of developing rats[J]. NIDA NOTES, 2000,15(2):6- 7.
  • 4Newcomer JW, Fanber NB, Jevbovic TV, et al. Ketamine- induced NMDA receptor hypofunction as a model of memory impairment and psychosis[J]. Neuropsychopharmacology, 1999,20(2 ): 106 - 118.
  • 5.国际麻醉品管制局1999年报告[R].联合国国际麻醉品管理局,2000.42-43.
  • 6国家基本药物领导小组办公室.国家基本药物品种目录[M].北京:国家基本药物领导小组办公室,1996.4..
  • 7国家禁毒委员会办公室.关于转发《关于氯胺酮管理问题的通知》的通知[Z].禁毒办通字[2001]24号[Z].,..
  • 8Lahti AC, Koffel B, LaPorte D, et al. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia of noncompetitive NMDA receptor antagonists on opiate tolerance and physical dependence[J]. Neuropsychopharmacology, 1995,13(4):301 - 307.
  • 9Chu PS, Ma WK, Wong SC, et al. The destruction of the lowerurinary tract by ketamine abuse: a new syndrome? [ J]. BJU Int,2008, 102; 1616-1622.
  • 10Winstock AR, Mitcheson L, Gillatt DA, et al. The prevalenceand natural history of urinary symptoms among recreationalketamine users [ J ]. BJU Int,2012,110: 1762-1766.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部